Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Voyager Therapeutics, Inc. (VYGR) Going To Burn These Hedge Funds ?

The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don’t follow. Because of their pay structures, they have strong incentives to do the research necessary to beat the market. That’s why we pay close attention to what they think in small cap stocks. In this article, we take a closer look at Voyager Therapeutics, Inc. (NASDAQ:VYGR) from the perspective of those elite funds.

Hedge fund interest in Voyager Therapeutics, Inc. (NASDAQ:VYGR) shares was flat at the end of last quarter. This is usually a negative indicator. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Milacron Holdings Corp (NYSE:MCRN), SecureWorks Corp. (NASDAQ:SCWX), and H&E Equipment Services, Inc. (NASDAQ:HEES) to gather more data points. Our calculations also showed that VYGR isn’t among the 30 most popular stocks among hedge funds (see the video below).
5 Most Popular Stocks Among Hedge Funds
Video: Click the image to watch our video about the top 5 most popular hedge fund stocks.

Today there are a multitude of formulas investors have at their disposal to value their holdings. A couple of the most useful formulas are hedge fund and insider trading sentiment. Our researchers have shown that, historically, those who follow the best picks of the top hedge fund managers can beat the market by a significant amount (see the details here).

Thomas-Steyer-e1351513531594

Unlike former hedge manager, Dr. Steve Sjuggerud, who is convinced Dow will soar past 40000, our long-short investment strategy doesn’t rely on bull markets to deliver double digit returns. We only rely on hedge fund buy/sell signals. Let’s view the recent hedge fund action encompassing Voyager Therapeutics, Inc. (NASDAQ:VYGR).

How have hedgies been trading Voyager Therapeutics, Inc. (NASDAQ:VYGR)?

At the end of the second quarter, a total of 18 of the hedge funds tracked by Insider Monkey were long this stock, a change of 0% from the first quarter of 2019. The graph below displays the number of hedge funds with bullish position in VYGR over the last 16 quarters. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

VYGR_oct2019

The largest stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR) was held by Partner Fund Management, which reported holding $57.6 million worth of stock at the end of March. It was followed by Casdin Capital with a $30.7 million position. Other investors bullish on the company included Armistice Capital, Farallon Capital, and Renaissance Technologies.

Because Voyager Therapeutics, Inc. (NASDAQ:VYGR) has faced a decline in interest from the entirety of the hedge funds we track, it’s easy to see that there exists a select few funds who were dropping their entire stakes by the end of the second quarter. Interestingly, Phill Gross and Robert Atchinson’s Adage Capital Management dumped the biggest position of the “upper crust” of funds followed by Insider Monkey, totaling an estimated $7.2 million in stock. Mark Lampert’s fund, Biotechnology Value Fund / BVF Inc, also said goodbye to its stock, about $5.9 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest stayed the same (this is a bearish signal in our experience).

Let’s now take a look at hedge fund activity in other stocks similar to Voyager Therapeutics, Inc. (NASDAQ:VYGR). These stocks are Milacron Holdings Corp (NYSE:MCRN), SecureWorks Corp. (NASDAQ:SCWX), H&E Equipment Services, Inc. (NASDAQ:HEES), and Middlesex Water Company (NASDAQ:MSEX). All of these stocks’ market caps are similar to VYGR’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
MCRN 13 60802 -11
SCWX 9 19866 -3
HEES 12 37700 -1
MSEX 9 49252 0
Average 10.75 41905 -3.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 10.75 hedge funds with bullish positions and the average amount invested in these stocks was $42 million. That figure was $195 million in VYGR’s case. Milacron Holdings Corp (NYSE:MCRN) is the most popular stock in this table. On the other hand SecureWorks Corp. (NASDAQ:SCWX) is the least popular one with only 9 bullish hedge fund positions. Compared to these stocks Voyager Therapeutics, Inc. (NASDAQ:VYGR) is more popular among hedge funds. Our calculations showed that top 20 most popular stocks among hedge funds returned 24.4% in 2019 through September 30th and outperformed the S&P 500 ETF (SPY) by 4 percentage points. Unfortunately VYGR wasn’t nearly as popular as these 20 stocks and hedge funds that were betting on VYGR were disappointed as the stock returned -36.8% during the third quarter and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 20 most popular stocks among hedge funds as many of these stocks already outperformed the market in Q3.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.